Summary: Protealis has achieved a major milestone by securing European regulatory approval for MagNfix™, its proprietary biological soybean inoculant seed coating. Alongside this approval, the company has registered five new high-performance soybean varieties across Europe. This includes commercial entry into Poland and the registration of France’s first ultra-early maturity group (MG) 0000 variety, equipping European farmers with ready-to-sow, climate-adapted seeds.
Protealis Secures EU Approval for MagNfix™ Inoculant and Launches Five New Soybean Varieties
Ghent, Belgium — March 5, 2026
Protealis, the European specialist in non-GMO legume seeds and seed technologies, today announces several milestones that significantly strengthen its position in a fast-growing European soybean market. The company has obtained European regulatory approval from EFCI (EU Fertilising Products Regulation (FPR) 2019/1009) for MagNfix™, its first biological solution. MagNfix™ is a proprietary soybean inoculant seed coating designed to support higher soybean yield and protein content.
In independent multi-location registration trials, MagNfix™ demonstrated yield increases of +31% on average compared to reference inoculants and a +7% improvement in protein content versus peers. The formulation offers a shelf life of up to three months and is delivered as a ready-to-sow coated seed, eliminating the need for on-farm inoculation.
“With the European regulatory approval of MagNfix™, Protealis is entering the biologicals market alongside its core activity in soybean seed breeding and commercialization in Europe,” said David Buckeridge, Chairman of the Board of Directors of Protealis. “This combination of advanced genetics with proprietary biologicals can boost Europe’s domestic plant protein production in a way that works for farmers, economically and agronomically.”
At the same time, Protealis succeeded in the registration of five new soybean varieties, expanding its portfolio from 9 varieties in 2025 to 14 today. These non-GMO genetics are specifically developed to thrive across colder northern and north-central European regions.
- PRO Hekla (MG 0000, France): The company’s first ultra-early variety suited to grow in colder areas in the north of France.
- PRO Dinara and PRO Katla (MG 000, Poland): Marking Protealis’ commercial entry into Poland, a fast-growing market with potential to reach 700,000 hectares.
- PRO Erebus (MG 00, Germany): The second MG 00 variety registered in Germany, combining high yield with excellent early canopy coverage for natural weed suppression.
- PRO Bingo (MG 000, Belgium): Strengthens the portfolio with excellent canopy closure and a strong yield–protein balance.
“This is a pivotal moment for the company as we now see efforts of technology investment maturing in products and unique USPs that will enable profitable, local soybean cultivation right here in Europe,” said Benjamin Laga, CEO of Protealis. “Protealis has addressed challenges by combining climate-adapted genetics and advanced breeding technologies—including AI-driven selection—with our proprietary MagNfix™ inoculant into a ready-to-sow solution.”
Following regulatory approval, Protealis will initiate a phased pre-commercial rollout during the current season with selected distribution partners in key markets including Poland, France, and Germany, ahead of a broader commercial launch in 2027.
Leave a Reply